ES2586408T3 - Preparación de intermedios de micafungina - Google Patents

Preparación de intermedios de micafungina Download PDF

Info

Publication number
ES2586408T3
ES2586408T3 ES12754018.5T ES12754018T ES2586408T3 ES 2586408 T3 ES2586408 T3 ES 2586408T3 ES 12754018 T ES12754018 T ES 12754018T ES 2586408 T3 ES2586408 T3 ES 2586408T3
Authority
ES
Spain
Prior art keywords
compound
formula
salt
residues
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12754018.5T
Other languages
English (en)
Spanish (es)
Inventor
Roland Barth
Kerstin Knepper
Hubert Sturm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of ES2586408T3 publication Critical patent/ES2586408T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ES12754018.5T 2011-09-09 2012-09-07 Preparación de intermedios de micafungina Active ES2586408T3 (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP11180686 2011-09-09
EP11180689 2011-09-09
EP11180690 2011-09-09
EP11180686 2011-09-09
EP11180690 2011-09-09
EP11180689 2011-09-09
PCT/EP2012/067475 WO2013034670A1 (en) 2011-09-09 2012-09-07 Preparation of micafungin intermediates

Publications (1)

Publication Number Publication Date
ES2586408T3 true ES2586408T3 (es) 2016-10-14

Family

ID=46796632

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12754018.5T Active ES2586408T3 (es) 2011-09-09 2012-09-07 Preparación de intermedios de micafungina

Country Status (9)

Country Link
US (2) US20140329989A1 (hu)
EP (1) EP2763971B1 (hu)
KR (1) KR20140069097A (hu)
CN (1) CN103917531B (hu)
DK (1) DK2763971T3 (hu)
ES (1) ES2586408T3 (hu)
HU (1) HUE029720T2 (hu)
RU (1) RU2014113624A (hu)
WO (1) WO2013034670A1 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102627689B (zh) * 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
WO2016056023A2 (en) * 2014-10-07 2016-04-14 Alaparthi Lakshmi Prasad Intermediates and processes to prepare micafungin
CN106866650A (zh) * 2017-01-09 2017-06-20 博瑞生物医药泰兴市有限公司 一种米卡芬净的合成与提纯方法
CN111606901A (zh) * 2020-06-16 2020-09-01 大桐制药(中国)有限责任公司 一种米卡芬净侧链中间体的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0788511T3 (da) 1994-10-07 2003-03-31 Fujisawa Pharmaceutical Co Cykliske hexapeptider med antibiotisk aktivitet
FR2794747B1 (fr) * 1999-06-09 2004-04-16 Hoechst Marion Roussel Inc Nouveaux derives de l'echinocandine, leur procede de preparation et leur application comme anti-fongiques
WO2004014879A1 (en) 2002-08-08 2004-02-19 Fujisawa Pharmaceutical Co., Ltd. New process

Also Published As

Publication number Publication date
EP2763971A1 (en) 2014-08-13
DK2763971T3 (en) 2016-07-18
KR20140069097A (ko) 2014-06-09
RU2014113624A (ru) 2015-10-20
US20160264628A1 (en) 2016-09-15
CN103917531B (zh) 2016-08-24
HUE029720T2 (hu) 2017-03-28
US20140329989A1 (en) 2014-11-06
EP2763971B1 (en) 2016-06-08
WO2013034670A1 (en) 2013-03-14
CN103917531A (zh) 2014-07-09

Similar Documents

Publication Publication Date Title
AU2021202403B2 (en) Methods of preparing cytotoxic benzodiazepine derivatives
ES2586408T3 (es) Preparación de intermedios de micafungina
IL174951A (en) METHOD FOR MAKING AMINO CROTONIL COMPOUNDS
ES2769255T3 (es) Métodos para fabricar inhibidores de la proteína desacetilasa
US9012641B2 (en) Crystalline forms of Prasugrel salts
KR102593509B1 (ko) 질소 머스타드 유도체의 제조 방법
AU2010289802C1 (en) Synthesis of a neurostimulative piperazine
WO2012062036A1 (zh) 一种含培南类侧链的双环中间体的制备方法及其应用
ES2594708T3 (es) Derivados novedosos de benzamida
JP5476541B2 (ja) テロメラーゼ阻害剤
US20070135471A1 (en) Methods for preparing irinotecan
CA3104956C (en) Novel lxr modulators with bicyclic core moiety
KR20230117416A (ko) 아미노피리미딘계 fak 억제제 화합물의 합성 방법
Simón et al. Xanthone Receptors as Oxyanion‐Hole Mimics in Artificial Enzymes
EP2754662A1 (en) Efficient process for the preparation of Lapatinib and salts thereof by means of new intermediates
Gao et al. Synthesis and structures of new chiral diamide‐ester macrocycles
WO2015150890A1 (en) A process for preparation of trans-sulfuric acid mono-{2-(5-(3-amino-propyl)-[1,3,4]oxadiazol-2-yl]-7-oxo-1,6-diazabicyclo [3.2.1] oct-6-yl}ester
CA2676162A1 (en) Method for producing ammonium hexafluorophosphates
WO2011110199A1 (en) A process for amidation of pyrrole carboxylate compounds
CA3224971A1 (en) Process for preparing aficamten
JP6440250B2 (ja) チオアミド誘導体
TW202233574A (zh) 肽之製造方法、保護基形成用試藥及縮合多環化合物
WO2008019074A1 (en) Processes for the preparation of 4-chloro-3-methyl-5-(2-(2-(6-methylbenzo[d][1,3]dioxol-5-yl)acetyl)-3-thienylsulfonamido) isoxazole
ES2636817T3 (es) Procedimiento de síntesis de una hidracina útil en el tratamiento del virus del papiloma
TW202330509A (zh) 苯並呋喃衍生物的製備方法